• Blog
  • Buprenorphine Hydrochloride Market Report

    Buprenorphine Hydrochloride Market Report

    Buprenorphine Hydrochloride Market Report
    Report code - SR1098 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Buprenorphine Hydrochloride Market, Dynamics, Trends, and Market Insights
    See more...

    Impact of COVID-19 on Buprenorphine Hydrochloride Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on Buprenorphine Hydrochloride Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The buprenorphine hydrochloride market is projected to grow from USD xx Million in 2020 to USD xx Million by 2026 at a CAGR of over x % during the forecast period.

    Figure: Buprenorphine Hydrochloride Market Size, 2020-2026 (USD Million)

    Buprenorphine-Hydrochloride-Market-Forecast

    Wish to get a free sample report? Click here.

    What is Buprenorphine hydrochloride?

    Buprenorphine hydrochloride is a type of medicine used to treat dependence or addiction to opioids. Buprenorphine comes from the class of drugs called mixed opioid agonist-antagonists. This type of drug helps prevent withdrawal symptoms caused by stopping other opioids. Buprenorphine is applicable after the treatment of all other opioids. This type of medication is strictly advised to consume as per the physicians’ guidelines.

    Key Players

    Key players operating in the buprenorphine hydrochloride market are-

    • Siegfried (Switzerland),
    • Resonance-labs (India),
    • Mallinckrodt (UK),
    • Sanofi (France),
    • Arevipharma (Germany),
    • Johnson Matthey (UK),
    • Rusan Pharma (India),
    • Unichemlabs (India),
    • Noramco (The U.S),
    • Sun Pharma (India), and
    • Micro Orgo Chem (India).

    Market Dynamics

    Increasing opioid addiction cases are observed as a significant factor driving the overall market for buprenorphine hydrochloride.

    • The consistently growing number of reported cases of opioid addiction is increasing due to the high availability and low cost of opioids.
    • This has increased risk factors across multiple regions.
    • The global buprenorphine hydrochloride market has witnessed significant growth in the last few years due to its wide range of applications.

    Segments' Analysis

    Type Trends

    By type, the buprenorphine hydrochloride market has been bifurcated into tablets and injection segments.

    • Under this segment, tablets form of buprenorphine hydrochlorides has been recorded for the highest share in the buprenorphine hydrochloride market.
    • Tablets are one of the most commonly prescribed medicines for opioid addiction.
    • This factor is making this segment report the highest demand in the overall buprenorphine hydrochloride market.
    • The medication administered through injections making the segment register significant growth over the forecast period.

    Regional Trends

    Based on geography, the market is analysed across North America, Europe, Asia Pacific, Middle East & Africa, and South America.

    • The North American region has witnessed the highest market share of over in 2020 and is projected to grow at a high CAGR during the review period.
    • This is mainly attributed to the growing customer demand for buprenorphine hydrochlorides across the regions.
    • Moreover, the growing count of opioid addiction cases is making the Asia Pacific region witness the highest CAGR for the buprenorphine hydrochloride market during the forecast period.

    COVID-19 Impact on Buprenorphine Hydrochloride Market

    The ongoing COVID-19 pandemic has to some extent influenced the buprenorphine hydrochloride market. This is mainly due to soaring coronavirus cases, implementation of stringent lockdown measures, and limited movement of people to curb the spread of the virus.

    Patients’ inability for direct consultation has affected the demand for buprenorphine hydrochloride across the world.   Moreover, the nations’ interest is largely shifted towards COVID vaccines. The consistently growing cases of opioid addiction have maintained the growth of the buprenorphine hydrochloride market even during COVID times. 

    Critical Questions Answered in the Report

    • What are the key trends in the buprenorphine hydrochloride market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in next five years?
    • What is the impact of COVID-19 on the buprenorphine hydrochloride market?
    • What are the key strategies adopted by the major vendors to lead in the buprenorphine hydrochloride market?
    • What is the market share of the top vendors?

    Target Audience

    Here is the list of the group of customers that the Buprenorphine Hydrochloride market hopes to have the greatest opportunity to convert-

    • Manufacturing Organizations
    • Distributors & Suppliers
    • Government as well as Independent Regulatory Authorities
    • Research Institute / Education Institute
    • Potential Investors

    Wish to know more about the study? Click here

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].

    Frequently Asked Questions (FAQs)

    Buprenorphine hydrochloride is a type of medicine used to treat dependence or addiction to opioids. Buprenorphine comes from the class of drugs called mixed opioid agonist-antagonists.

    Siegfried (Switzerland), Resonance-labs (India), Mallinckrodt (UK), Sanofi (France), Arevipharma (Germany), Johnson Matthey (UK), Rusan Pharma (India), Unichemlabs (India), Noramco (The U.S), Sun Pharma (India) and Micro Orgo Chem (India) are among the key players in the buprenorphine hydrochloride market.

    North America is expected to grow at high CAGR in the buprenorphine hydrochloride market in the coming years.

    Tablets form of buprenorphine hydrochlorides has been recorded for the highest share in the buprenorphine hydrochloride market.

    Increasing opioid addiction cases is the major factor driving the growth of buprenorphine hydrochloride market.

    Manufacturing Organizations, Distributors & Suppliers, Government as well as Independent Regulatory Authorities, Research Institute / Education Institute, Potential Investors are the target audience in the buprenorphine hydrochloride market.

    •